NEW YORK (GenomeWeb) – Thermo Fisher Scientific and Swiss company Biognosys said today that they have signed a comarketing agreement for Thermo Fisher's Orbitrap mass spectrometers and Biognosys' Spectronaut Pulsar software.

The Spectronaut Pulsar software allows researchers to conduct data-independent acquisition (DIA) analyses using data from Orbitrap mass specs. DIA is a method for recording the spectral signatures from all components of a sample, and can be used as a universal method for global expression profiling.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.